Serum calprotectin as a novel biomarker for severity of COVID-19 disease
COVID-19 질병의 중증도에 대한 새로운 바이오마커로서의 혈청 칼프로텍틴
Article
[키워드] age
an area
Analysis
Biomarker
Biomarkers
blood cell
C-reactive protein
calprotectin
Care
clinical parameter
Clinical parameters
Clinical severity
cohort study
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 disease
COVID-19 patients
cross-sectional
diagnosis of COVID-19
disease
ferritin
fibrinogen
groups
hospitalized patient
hospitalized patients
ICU
ICU patient
ICU Patients
Inflammation
intensive care
intensive care unit
Laboratory
Logistic regression analysis
non-ICU
non-ICU patients
Patient
patients
patients hospitalized
patients with COVID-19
predict
procalcitonin
Prognosis
Prognostic value
reactant
regression analysis
reported
required
retrospective
ROC Curve
SARS-CoV-2
serum
severity of COVID-19
significantly higher
study population
the patient
two group
two groups
White blood cell
[DOI] 10.1007/s11845-021-02565-8 PMC 바로가기 [Article Type] Article
[DOI] 10.1007/s11845-021-02565-8 PMC 바로가기 [Article Type] Article